Charles Duncan

Stock Analyst at Cantor Fitzgerald

(1.57)
# 1642
Out of 5,386 analysts
304
Total ratings
Success rate
Average return
58 Stocks
Name Action PT Current % Upside Ratings Updated
ITCI Intra-Cellular Thera...
Reiterates: Neutral
132 132
n/a n/a 22 Apr 2, 2025
CMPS Compass Pathways
Reiterates: Overweight
n/a
n/a n/a 6 Mar 28, 2025
ACAD ACADIA Pharmaceutica...
Reiterates: Overweight
28 28
22.09 26.75% 21 Feb 27, 2025
JAZZ Jazz Pharmaceuticals
Downgrades: Neutral
140 150
107.03 40.15% 6 Feb 26, 2025
AXSM Axsome Therapeutics
Reiterates: Overweight
153 153
103.39 47.98% 22 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
14
12.39 12.99% 1 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
n/a
n/a n/a 1 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 17 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 7 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4 4
n/a n/a 9 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
51 58
31.98 81.36% 8 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
48 43
28.8 49.31% 5 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 7 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 15 Sep 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
155 155
125.44 23.57% 9 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 3 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
35 35
14.09 148.4% 6 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 13
4.79 171.4% 5 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 6 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 3 Jun 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 3 Jun 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
34 34
21.78 56.11% 9 Mar 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
330 330
n/a n/a 4 Feb 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
38 45
n/a n/a 2 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
52 50
29.82 67.67% 3 Oct 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
5
4.73 5.71% 1 Sep 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 7 Sep 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4
n/a n/a 4 Sep 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4
1.16 244.83% 4 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
58
32.37 79.18% 3 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
10
n/a n/a 4 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
110
1.02 10684.31% 4 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
80
3.78 2016.4% 5 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
172
n/a n/a 12 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
3
1.4 114.29% 2 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
16 11
9.48 16.03% 2 Dec 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
9 12
8.16 47.06% 2 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
146 168
6.37 2537.36% 6 Jun 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 5
n/a n/a 4 Apr 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
20
2.15 830.23% 1 Feb 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
200
14.57 1272.68% 3 Feb 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
52
n/a n/a 1 Jan 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
8 4
n/a n/a 3 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
24
1.78 1248.31% 1 Oct 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
372 144
2.13 6660.56% 6 Sep 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
26
n/a n/a 1 Sep 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
24 35
n/a n/a 3 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 4
1.49 168.46% 2 Jun 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
1224 1440
n/a n/a 4 May 19, 2020